(4R,6S)-6-[(1E)-2-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]ethenyl]-2,2-dimethyl-1,3-dioxane-4-acetic acid tert-butyl ester
98%
- Product Code: 49555
CAS:
147489-06-3
| Molecular Weight: | 517.637 g./mol | Molecular Formula: | C₃₂H₃₆FNO₄ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD12911897 | |
| Melting Point: | Boiling Point: | 604.6±55.0℃(Predicted) | |
| Density: | 1.184±0.06g/ml(Predicted) | Storage Condition: | 2-8°C, airtight, dry |
Product Description:
This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of statins, a class of drugs that lower cholesterol levels in the blood. Its specific structure is crucial for the development of active pharmaceutical ingredients (APIs) that inhibit HMG-CoA reductase, an enzyme involved in cholesterol production. The compound's unique stereochemistry and functional groups make it a key building block in creating molecules that are effective in managing cardiovascular diseases. Additionally, it is used in research and development to explore new therapeutic agents targeting lipid metabolism and related disorders. Its application is critical in ensuring the efficacy and safety of cholesterol-lowering medications.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White to off-white powder or crystals |
| PURITY | 97.5-100 |
| Infrared spectrum | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.250 | 10-20 days | Ft12,497.97 |
+
-
|
| 1.000 | 10-20 days | Ft34,692.63 |
+
-
|
| 5.000 | 10-20 days | Ft108,818.49 |
+
-
|
(4R,6S)-6-[(1E)-2-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]ethenyl]-2,2-dimethyl-1,3-dioxane-4-acetic acid tert-butyl ester
This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of statins, a class of drugs that lower cholesterol levels in the blood. Its specific structure is crucial for the development of active pharmaceutical ingredients (APIs) that inhibit HMG-CoA reductase, an enzyme involved in cholesterol production. The compound's unique stereochemistry and functional groups make it a key building block in creating molecules that are effective in managing cardiovascular diseases. Additionally, it is used in research and development to explore new therapeutic agents targeting lipid metabolism and related disorders. Its application is critical in ensuring the efficacy and safety of cholesterol-lowering medications.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :